MAPK14 and metabolic dysfunction-associated steatotic liver disease: These results indicate that NTP treatment suppresses the expression of inflammatory genes, phosphorylation of JNK, ERK, and p38, and hepatic macrophage infiltration in our MASLD mouse model.